PETROLEUM JELLY

PETROLEUM JELLY was reported 103 times

PETROLEUM JELLY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SENSORY PROCESSING SENSITIVITY 1 0.0227
1 BULLOUS IMPETIGO 1 0.0167
2 PLATELET AGGREGATION ABNORMAL 1 0.0066
3 ADRENAL SUPPRESSION 5 0.0059
4 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
5 OCULAR ROSACEA 1 0.0049
6 GINGIVAL OPERATION 1 0.0045
7 ADENOIDAL DISORDER 1 0.0038
8 SHOPLIFTING 1 0.0036
9 PERIORBITAL IRRITATION 1 0.0029
10 TRIGEMINAL NERVE DISORDER 1 0.0029
11 EAR OPERATION 1 0.0027
12 APPLICATION SITE LACERATION 1 0.0024
13 INSULIN RESISTANCE 5 0.0024
14 FAECAL VOMITING 1 0.0019
15 THEFT 1 0.0015
16 INFLAMMATORY PAIN 1 0.0015
17 GASTROINTESTINAL SURGERY 1 0.0013
18 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
19 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
20 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
21 BRONCHIAL SECRETION RETENTION 1 0.0008
22 APPLICATION SITE EROSION 1 0.0008
23 SUDDEN ONSET OF SLEEP 1 0.0007
24 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
25 MEAN CELL VOLUME DECREASED 1 0.0006
26 TRANSCRIPTION MEDICATION ERROR 1 0.0006
27 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
28 SKULL FRACTURE 1 0.0006
29 RESPIRATORY ALKALOSIS 1 0.0006
30 TONSILLAR HYPERTROPHY 1 0.0006
31 EROSIVE OESOPHAGITIS 1 0.0006
32 FIXED ERUPTION 1 0.0006
33 PUPIL FIXED 1 0.0006
34 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
35 DIFFUSE ALOPECIA 1 0.0005
36 INFECTED SKIN ULCER 1 0.0005
37 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
38 SELF-MEDICATION 2 0.0005
39 COMPULSIVE SHOPPING 1 0.0005
40 IMPULSE-CONTROL DISORDER 1 0.0005
41 HORDEOLUM 2 0.0005
42 SKIN TIGHTNESS 2 0.0004
43 EYELID IRRITATION 1 0.0004
44 RETINAL DISORDER 1 0.0004
45 GAMBLING DISORDER 1 0.0004
46 APPLICATION SITE HAEMORRHAGE 1 0.0004
47 IMMUNE-MEDIATED MYOSITIS 1 0.0004
48 VITREOUS HAEMORRHAGE 1 0.0004
49 SKIN HYPERTROPHY 1 0.0004
50 HAEMATOLOGICAL MALIGNANCY 1 0.0004
51 MULTIPLE-DRUG RESISTANCE 1 0.0003
52 SKIN WEEPING 1 0.0003
53 FACIAL BONES FRACTURE 1 0.0003
54 RHINOVIRUS INFECTION 1 0.0003
55 SKIN FISSURES 5 0.0003
56 BLEPHARITIS 1 0.0002
57 APPLICATION SITE DISCOLOURATION 1 0.0002
58 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
59 HEPATOTOXICITY 5 0.0002
60 VASCULAR DEVICE INFECTION 1 0.0002
61 ROSACEA 1 0.0002
62 EYE INFLAMMATION 2 0.0002
63 ENTEROCOCCAL INFECTION 1 0.0002
64 ANAL FISSURE 1 0.0002
65 STREPTOCOCCAL INFECTION 1 0.0002
66 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
67 MOUTH SWELLING 1 0.0002
68 INJECTION SITE VESICLES 1 0.0002
69 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
70 NASAL DRYNESS 1 0.0002
71 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
72 LARGE INTESTINE PERFORATION 1 0.0001
73 VISUAL FIELD DEFECT 1 0.0001
74 DERMATITIS BULLOUS 1 0.0001
75 MAJOR DEPRESSION 1 0.0001
76 APPLICATION SITE PAIN 3 0.0001
77 ARTHROPOD BITE 1 0.0001
78 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
79 GINGIVAL PAIN 1 0.0001
80 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
81 ESCHERICHIA INFECTION 1 0.0001
82 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
83 DRY SKIN 16 0.0001
84 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
85 ECZEMA 6 0.0001
86 DERMATITIS ATOPIC 6 0.0001
87 SKIN EXFOLIATION 9 0.0001
88 LIGAMENT SPRAIN 1 0.0001
89 TENDERNESS 1 0.0001
90 INJECTION SITE DISCOMFORT 1 0.0001
91 SCRATCH 1 0.0001
92 PHARYNGITIS STREPTOCOCCAL 1 0.0001
93 SKIN INFECTION 1 0.0001
94 OCULAR DISCOMFORT 1 0.0001
95 REBOUND EFFECT 1 0.0001
96 ELECTROLYTE IMBALANCE 1 0.0001
97 ADRENAL INSUFFICIENCY 1 0.0001
98 HAIR COLOUR CHANGES 1 0.0001
99 DERMATITIS ALLERGIC 1 0.0001
100 HEPATIC CYTOLYSIS 1 0.0001
101 IMMUNE SYSTEM DISORDER 1 0.0001
102 EAR INFECTION 2 0.0001
103 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
104 BLINDNESS UNILATERAL 1 0.0001
105 SKIN HAEMORRHAGE 1 0.0001
106 ECONOMIC PROBLEM 1 0.0001
107 THERAPEUTIC RESPONSE DECREASED 4 0.0001
108 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
109 DRUG DISPENSING ERROR 1 0.0001
110 HIP ARTHROPLASTY 1 0.0001
111 MUSCULOSKELETAL CHEST PAIN 1 0.0001
112 TENDONITIS 1 0.0001
113 THERAPY PARTIAL RESPONDER 1 0.0001
114 BASAL CELL CARCINOMA 1 0.0001
115 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
116 METABOLIC ACIDOSIS 2 0.0001
117 PHOTOSENSITIVITY REACTION 1 0.0001
118 CANDIDA INFECTION 1 0.0001
119 MUSCULOSKELETAL DISCOMFORT 1 0.0001
120 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
121 TOOTHACHE 1 0.0001
122 CONJUNCTIVITIS 1 0.0001
123 THINKING ABNORMAL 1 0.0001
124 PROTEINURIA 1 0.0001
125 SLEEP APNOEA SYNDROME 1 0.0001
126 ACUTE RESPIRATORY FAILURE 1 0.0001
127 HERNIA 1 0.0001
128 EAR PAIN 1 0.0001
129 BONE PAIN 3 0.0001
130 DISABILITY 1 0.0001
131 HAEMATOCRIT DECREASED 1 0.0001
132 ILL-DEFINED DISORDER 3 0.0000
133 PERITONITIS 1 0.0000
134 EATING DISORDER 1 0.0000
135 FAECES DISCOLOURED 1 0.0000
136 STEVENS-JOHNSON SYNDROME 1 0.0000
137 TRANSAMINASES INCREASED 1 0.0000
138 COLITIS ULCERATIVE 2 0.0000
139 RASH PAPULAR 1 0.0000
140 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
141 INJECTION SITE URTICARIA 1 0.0000
142 DRY EYE 2 0.0000
143 PRODUCT COMPLAINT 1 0.0000
144 DIPLOPIA 1 0.0000
145 JOINT STIFFNESS 1 0.0000
146 ANHEDONIA 1 0.0000
147 BLOOD BILIRUBIN INCREASED 1 0.0000
148 FREQUENT BOWEL MOVEMENTS 1 0.0000
149 SKIN LESION 1 0.0000
150 WOUND 1 0.0000
151 EYE PAIN 2 0.0000
152 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
153 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
154 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
155 NASAL CONGESTION 2 0.0000
156 LACRIMATION INCREASED 1 0.0000
157 FEELING HOT 2 0.0000
158 INJECTION SITE RASH 1 0.0000
159 SWELLING 3 0.0000
160 DRUG-INDUCED LIVER INJURY 1 0.0000
161 HEAD INJURY 1 0.0000
162 PRURITUS 12 0.0000
163 NIGHT SWEATS 1 0.0000
164 STAPHYLOCOCCAL INFECTION 1 0.0000
165 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
166 EXPIRED PRODUCT ADMINISTERED 1 0.0000
167 FUNGAL INFECTION 1 0.0000
168 EYE PRURITUS 1 0.0000
169 RASH MACULAR 1 0.0000
170 INJURY 2 0.0000
171 HYPOXIA 1 0.0000
172 LYMPHADENOPATHY 1 0.0000
173 RASH 12 0.0000
174 C-REACTIVE PROTEIN INCREASED 1 0.0000
175 EYE SWELLING 1 0.0000
176 INJECTION SITE SWELLING 2 0.0000
177 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
178 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
179 RHABDOMYOLYSIS 1 0.0000
180 ROAD TRAFFIC ACCIDENT 1 0.0000
181 HYPOACUSIS 1 0.0000
182 CONDITION AGGRAVATED 7 0.0000
183 SEPTIC SHOCK 1 0.0000
184 INJECTION SITE PAIN 7 0.0000
185 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
186 PULMONARY OEDEMA 1 0.0000
187 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
188 VISION BLURRED 3 0.0000
189 SKIN IRRITATION 1 0.0000
190 TINNITUS 1 0.0000
191 SKIN DISCOLOURATION 1 0.0000
192 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
193 OCULAR HYPERAEMIA 1 0.0000
194 COMA 1 0.0000
195 RASH ERYTHEMATOUS 1 0.0000
196 CONTUSION 2 0.0000
197 DRUG INTOLERANCE 2 0.0000
198 ILLNESS 2 0.0000
199 INFLAMMATION 1 0.0000
200 PANCREATITIS 1 0.0000
201 DEPRESSED MOOD 1 0.0000
202 DISTURBANCE IN ATTENTION 1 0.0000
203 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
204 HAEMATOCHEZIA 1 0.0000
205 INFLUENZA 2 0.0000
206 BLISTER 1 0.0000
207 OXYGEN SATURATION DECREASED 1 0.0000
208 FLATULENCE 1 0.0000
209 LETHARGY 1 0.0000
210 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
211 VERTIGO 1 0.0000
212 RHINORRHOEA 1 0.0000
213 PRODUCT DOSE OMISSION 1 0.0000
214 BLOOD CREATININE INCREASED 1 0.0000
215 INJECTION SITE PRURITUS 1 0.0000
216 OFF LABEL USE 13 0.0000
217 HEPATIC ENZYME INCREASED 1 0.0000
218 BURNING SENSATION 1 0.0000
219 SLEEP DISORDER 1 0.0000
220 THERAPY INTERRUPTED 1 0.0000
221 SKIN BURNING SENSATION 1 0.0000
222 CONSTIPATION 3 0.0000
223 RESPIRATORY FAILURE 1 0.0000
224 EPISTAXIS 1 0.0000
225 ACNE 1 0.0000
226 DIABETES MELLITUS 1 0.0000
227 ABDOMINAL PAIN 3 0.0000
228 DRY MOUTH 1 0.0000
229 INFLUENZA LIKE ILLNESS 1 0.0000
230 RENAL IMPAIRMENT 1 0.0000
231 BALANCE DISORDER 1 0.0000
232 INTENTIONAL PRODUCT MISUSE 1 0.0000
233 MUSCULOSKELETAL STIFFNESS 1 0.0000
234 GASTROINTESTINAL DISORDER 1 0.0000
235 ADVERSE DRUG REACTION 1 0.0000
236 CARDIAC DISORDER 1 0.0000
237 PRODUCT USE ISSUE 2 0.0000
238 DYSPHAGIA 1 0.0000
239 PRODUCT DOSE OMISSION ISSUE 3 0.0000
240 ALOPECIA 2 0.0000
241 HEART RATE INCREASED 1 0.0000
242 SYNCOPE 1 0.0000
243 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
244 CHEST DISCOMFORT 1 0.0000
245 SINUSITIS 1 0.0000
246 ARTHRALGIA 4 0.0000
247 ABDOMINAL DISTENSION 1 0.0000
248 HYPERTENSION 2 0.0000
249 MUSCULAR WEAKNESS 1 0.0000
250 INCORRECT DOSE ADMINISTERED 2 0.0000
251 DECREASED APPETITE 2 0.0000
252 DISEASE PROGRESSION 1 0.0000
253 DRUG INEFFECTIVE 11 0.0000
254 JOINT SWELLING 1 0.0000
255 EMOTIONAL DISTRESS 1 0.0000
256 PAIN 5 0.0000
257 INJECTION SITE ERYTHEMA 1 0.0000
258 PSORIASIS 1 0.0000
259 MEMORY IMPAIRMENT 1 0.0000
260 WEIGHT DECREASED 2 0.0000
261 BLOOD PRESSURE INCREASED 1 0.0000
262 ACUTE KIDNEY INJURY 1 0.0000
263 PERIPHERAL SWELLING 1 0.0000
264 HEADACHE 4 0.0000
265 PARAESTHESIA 1 0.0000
266 DIARRHOEA 4 0.0000
267 CONFUSIONAL STATE 1 0.0000
268 URTICARIA 1 0.0000
269 ABDOMINAL DISCOMFORT 1 0.0000
270 TOXICITY TO VARIOUS AGENTS 1 0.0000
271 PYREXIA 2 0.0000
272 COVID-19 1 0.0000
273 MUSCLE SPASMS 1 0.0000
274 NASOPHARYNGITIS 1 0.0000
275 ASTHENIA 2 0.0000
276 ERYTHEMA 1 0.0000
277 ABDOMINAL PAIN UPPER 1 0.0000
278 DEPRESSION 1 0.0000
279 BACK PAIN 1 0.0000
280 VOMITING 2 0.0000
281 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
282 DIZZINESS 2 0.0000
283 NAUSEA 3 0.0000
284 INSOMNIA 1 0.0000
285 COUGH 1 0.0000
286 ANXIETY 1 0.0000
287 PAIN IN EXTREMITY 1 0.0000
288 FATIGUE 1 0.0000